INDU.A

333.4

+1.28%↑

INDU.C

333.5

+1.24%↑

AZA

307.9

-3.18%↓

ORES

119.82

+1.66%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.5

+1.24%↑

AZA

307.9

-3.18%↓

ORES

119.82

+1.66%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.5

+1.24%↑

AZA

307.9

-3.18%↓

ORES

119.82

+1.66%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.5

+1.24%↑

AZA

307.9

-3.18%↓

ORES

119.82

+1.66%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.5

+1.24%↑

AZA

307.9

-3.18%↓

ORES

119.82

+1.66%↑

Search

Biotage AB

Închisă

140.6 -0.64

Rezumat

Modificarea prețului

24h

Curent

Minim

140.1

Maxim

141.5

Indicatori cheie

By Trading Economics

Venit

97M

158M

Vânzări

92M

582M

P/E

Medie Sector

25.507

20.525

EPS

1.416

Randament dividend

1.82

Marjă de profit

27.148

Angajați

680

EBITDA

111M

222M

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.82%

4.36%

Următoarele câștiguri

16 iul. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-3.9B

7.2B

Deschiderea anterioară

141.24

Închiderea anterioară

140.6

Biotage AB Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

22 apr. 2025, 06:50 UTC

Achiziții, Fuziuni, Preluări

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

22 apr. 2025, 06:04 UTC

Achiziții, Fuziuni, Preluări

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22 apr. 2025, 06:03 UTC

Achiziții, Fuziuni, Preluări

KKR: Biotage Board Recommends Shareholders Accept Offer

22 apr. 2025, 06:02 UTC

Achiziții, Fuziuni, Preluări

KKR: Offer Values Biotage at SEK11.61B

22 apr. 2025, 06:02 UTC

Achiziții, Fuziuni, Preluări

KKR Makes SEK145 a Share Bid For Biotage

Comparație

Modificare preț

Biotage AB Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.